Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.ejca.2008.10.026 | New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) |
| https://doi.org/10.1056/nejmoa043330 | Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma |
| https://doi.org/10.1093/jnci/85.5.365 | The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology |
| https://doi.org/10.1093/jnci/92.3.205 | New Guidelines to Evaluate the Response to Treatment in Solid Tumors |
| https://doi.org/10.1016/s1470-2045(09)70025-7 | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial |
| https://doi.org/10.1016/s0140-6736(13)62422-8 | Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis |
| https://doi.org/10.1056/nejmoa020191 | Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis |
| https://doi.org/10.1056/nejmoa032641 | Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer |
| https://doi.org/10.1016/j.eururo.2005.12.031 | Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials |
| https://doi.org/10.1056/nejmoa060829 | Chemotherapy with Preoperative Radiotherapy in Rectal Cancer |
| https://doi.org/10.1056/nejmoa0908806 | Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer |
| https://doi.org/10.1016/s1470-2045(17)30074-8 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics |
| https://doi.org/10.1016/s0140-6736(12)60651-5 | Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial |
| https://doi.org/10.1016/s0140-6736(08)60455-9 | Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial |
| https://doi.org/10.1016/j.ejca.2016.03.081 | RECIST 1.1—Update and clarification: From the RECIST committee |
| https://doi.org/10.1056/nejmoa032312 | A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer |
| https://doi.org/10.1056/nejmoa1802357 | Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma |
| https://doi.org/10.1016/s1470-2045(14)70460-7 | Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial |
| https://doi.org/10.1056/nejmoa071028 | Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer |
| https://doi.org/10.1016/s0140-6736(02)09408-4 | Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial |
| https://doi.org/10.1016/s0140-6736(04)17098-0 | Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial |
| https://doi.org/10.1056/nejm199707313370502 | Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin |
| https://doi.org/10.1016/s0140-6736(01)06103-7 | Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial |
| https://doi.org/10.1056/nejm199707173370304 | Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus |
| https://doi.org/10.1093/jnci/88.13.890 | Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial |
| https://doi.org/10.1056/nejmoa1611299 | Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy |
| https://doi.org/10.1016/s1470-2045(13)70447-9 | Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial |
| https://doi.org/10.1016/s0022-5347(05)64273-5 | Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials |
| https://doi.org/10.1016/s0140-6736(01)06535-7 | Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study |
| https://doi.org/10.1093/jnci/92.14.1143 | Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial |
| https://doi.org/10.1097/00000658-199912000-00006 | Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region |
| https://doi.org/10.1016/s1470-2045(15)70122-1 | Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial |
| https://doi.org/10.1016/j.eururo.2013.06.003 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 |
| https://doi.org/10.1056/nejmoa1611977 | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma |
| https://doi.org/10.1016/s1470-2045(14)70063-4 | Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial |
| https://doi.org/10.1016/s0140-6736(05)67101-2 | Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) |
| https://doi.org/10.1016/s0140-6736(06)69121-6 | Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis |
| https://doi.org/10.1016/j.ejca.2010.10.013 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours |
| https://doi.org/10.1016/j.eururo.2011.03.017 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update |
| https://doi.org/10.1038/nrclinonc.2016.162 | Imaging biomarker roadmap for cancer studies |
| https://doi.org/10.1016/j.eururo.2006.11.013 | A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma |
| https://doi.org/10.1016/j.eururo.2010.12.013 | A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma |
| https://doi.org/10.1093/jnci/92.9.699 | Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results |
| https://doi.org/10.1016/s0140-6736(05)67070-5 | Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial |
| https://doi.org/10.1016/s1470-2045(19)30718-1 | Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation |
| https://doi.org/10.1016/s1470-2045(14)70379-1 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial |
| https://doi.org/10.1016/s0140-6736(19)30418-0 | Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study |
| https://doi.org/10.1056/nejmoa1707358 | Lomustine and Bevacizumab in Progressive Glioblastoma |
| https://doi.org/10.1056/nejmoa010874 | Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation |
| https://doi.org/10.1016/s1470-2045(10)70223-0 | External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study |
| https://doi.org/10.1016/s0959-8049(01)00448-8 | Quality of life research within the EORTC—the EORTC QLQ-C30 |
| https://doi.org/10.1016/j.ejca.2006.01.030 | KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours |
| https://doi.org/10.1016/s0140-6736(12)61253-7 | Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) |
| https://doi.org/10.1056/nejm199501263320403 | Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia |
| https://doi.org/10.1016/s0959-8049(00)00186-6 | A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients |
| https://doi.org/10.1158/0008-5472.can-08-3845 | Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas |
| https://doi.org/10.1001/jama.2017.21903 | Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols |
| https://doi.org/10.1056/nejm199808273390904 | Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia |
| https://doi.org/10.1038/sj.onc.1208561 | Identification of molecular apocrine breast tumours by microarray analysis |
| https://doi.org/10.1016/j.eururo.2009.06.028 | Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy |
| https://doi.org/10.1016/j.eururo.2008.04.051 | EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder |
| https://doi.org/10.1200/jco.2005.04.6078 | Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial |
| https://doi.org/10.1056/nejmoa1412379 | Adjuvant Ovarian Suppression in Premenopausal Breast Cancer |
| https://doi.org/10.1016/s1470-2045(13)70599-0 | Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study |
| https://doi.org/10.1056/nejm199503093321002 | The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer |
| https://doi.org/10.1016/s1470-2045(22)00518-6 | Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial |
| https://doi.org/10.1093/jnci/djk093 | Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer |
| https://doi.org/10.1016/s0360-3016(96)00352-5 | A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844 |
| https://doi.org/10.1016/0167-8140(92)90242-m | Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy |
| https://doi.org/10.1016/j.radonc.2003.09.011 | CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines |
| https://doi.org/10.1016/s0302-2838(02)00068-4 | Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies |
| https://doi.org/10.1016/j.ejca.2005.06.022 | The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care |
| https://doi.org/10.1016/s1470-2045(14)71156-8 | Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial |
| https://doi.org/10.1097/00000658-198811000-00011 | Preoperative Radiotherapy as Adjuvant Treatment in Rectal Cancer |
| https://doi.org/10.1093/jnci/djx015 | Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial |
| https://doi.org/10.1016/j.eururo.2009.04.038 | An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer |
| https://doi.org/10.1016/s1470-2045(09)70200-1 | Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials |
| https://doi.org/10.1016/s0140-6736(08)61033-8 | Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial |
| https://doi.org/10.1016/s1470-2045(11)70057-2 | Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas |
| https://doi.org/10.1093/annonc/mdx310 | ESMO-Magnitude of Clinical Benefit Scale version 1.1 |
| https://doi.org/10.1016/j.eururo.2015.06.045 | EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin |
| https://doi.org/10.1200/jco.20005.14.589 | Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada |
| https://doi.org/10.1038/nm.1908 | A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer |
| https://doi.org/10.1200/jco.2005.02.113 | Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results—EORTC 22921 |
| https://doi.org/10.1016/s0140-6736(10)61268-8 | Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial |
| https://doi.org/10.1016/s1470-2045(12)70346-7 | Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial |
| https://doi.org/10.1183/13993003.01245-2015 | Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries |
| https://doi.org/10.1016/s1470-2045(14)71199-4 | Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data |
| https://doi.org/10.1016/s1470-2045(07)70384-4 | Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 |
| https://doi.org/10.1007/bf01967060 | Fungal infections in cancer patients: An international autopsy survey |
| https://doi.org/10.1016/s1470-2045(12)70042-6 | Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial |
| https://doi.org/10.1200/jco.1998.16.1.145 | Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. |
| https://doi.org/10.1016/j.eururo.2013.06.044 | Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904 |
| https://doi.org/10.1016/j.ejca.2008.01.019 | Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) |
| https://doi.org/10.1016/s0167-8140(97)00079-0 | Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial |
| https://doi.org/10.1016/j.eururo.2012.10.039 | Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance |
| https://doi.org/10.1200/jco.2005.01.112 | Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials |
| https://doi.org/10.1016/s1470-2045(16)30313-8 | Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study |
| https://doi.org/10.1111/j.1468-1293.2010.00857.x | Late presentation of HIV infection: a consensus definition |
| https://doi.org/10.1016/j.ejca.2008.07.030 | An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer |